29997611000001109: Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual medicinal product\Proguanil 100mg / Atovaquone 250mg tablets\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Proguanil + Atovaquone\Proguanil 100mg / Atovaquone 250mg tablets\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing atovaquone\Product containing atovaquone and proguanil\Proguanil + Atovaquone\Proguanil 100mg / Atovaquone 250mg tablets\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing proguanil\Product containing atovaquone and proguanil\Proguanil + Atovaquone\Proguanil 100mg / Atovaquone 250mg tablets\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing biguanide\Medicinal product containing biguanide and acting as antimalarial agent (product)\Product containing proguanil\Product containing atovaquone and proguanil\Proguanil + Atovaquone\Proguanil 100mg / Atovaquone 250mg tablets\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing ketone\Product containing atovaquone\Product containing atovaquone and proguanil\Proguanil + Atovaquone\Proguanil 100mg / Atovaquone 250mg tablets\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antiparasitic agent (product)\Medicinal product acting as antiprotozoal agent (product)\Medicinal product acting as antimalarial agent (product)\Medicinal product containing biguanide and acting as antimalarial agent (product)\Product containing proguanil\Product containing atovaquone and proguanil\Proguanil + Atovaquone\Proguanil 100mg / Atovaquone 250mg tablets\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antiparasitic agent (product)\Medicinal product acting as antiprotozoal agent (product)\Product containing atovaquone\Product containing atovaquone and proguanil\Proguanil + Atovaquone\Proguanil 100mg / Atovaquone 250mg tablets\Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

93627501000001113 Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

93627601000001112 Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Proguanil 100mg / Atovaquone 250mg tablets	false	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Proguanil 100mg / Atovaquone 250mg tablets	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has active ingredient	Atovaquone	false	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has active ingredient	Proguanil	false	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Proguanil hydrochloride	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Atovaquone	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet	Has AMP	True	Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
93627501000001113	Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
93627601000001112	Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module